We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Melanocyte Stem Cells and UVB Responsible for Some Cancers

By LabMedica International staff writers
Posted on 01 Nov 2017
Print article
Image: Fluorescence microscopy reveals melanoma (red, left; black, right) emerging from melanocyte stem cells (Photo courtesy of Hyeongsun Moon and Andrew White, Cornell University).
Image: Fluorescence microscopy reveals melanoma (red, left; black, right) emerging from melanocyte stem cells (Photo courtesy of Hyeongsun Moon and Andrew White, Cornell University).
Cancer researchers working with mouse melanoma models have identified a mechanism responsible for the initiation of skin cancer through the interaction of ultraviolet light (UVB) and melanocyte stem cells.

Melanoma is one of the deadliest cancers, yet the cells of origin and mechanisms of tumor initiation have not been identified. The majority of melanomas emerge from clear skin without a precursor lesion, but it is not known whether these melanomas can arise from melanocyte stem cells (MCSCs).

To clarify this point, investigators at Cornell University (Ithaca, NY, USA) employed mouse models to define the role of MCSCs as melanoma cells of origin. In particular, they evaluated the effect of the Hmga2 protein in MCSCs. This protein is encoded by the HMGA2 gene and belongs to the non-histone chromosomal high-mobility group (HMG) protein family. HMG proteins contain structural DNA-binding domains and may act as transcriptional regulating factors that function as architectural factors. The expression of HMGA2 in adult tissues is commonly associated with both malignant and benign tumor formation, as well as certain characteristic cancer-promoting mutations.

The investigators worked with mice carrying mutated MCSCs with intact HMGA2 and with another group in which HMGA2 had been deleted.

Results published in the October 12, 2017, online edition of the journal Cell Stem Cell revealed that Hmga2 (High-mobility group AT-hook 2) in the skin played a critical role in UVB-mediated melanoma formation and that abrogation of Hmga2 function in the microenvironment could suppress MCSC-originating cutaneous melanomas. The investigators concluded that melanomas originated from melanoma-competent MCSCs upon stimulation by UVB, which induced MCSC activation and translocation via an inflammation-dependent process.

“If you had mutations that were sufficient for melanoma, everything would be fine until you went out and got a sunburn,” said senior author Dr. Andrew White, assistant professor of biomedical sciences at Cornell University. “We have an actual mechanism, with Hmga2, that can be explored in the future and could be a way we can prevent melanomas from happening.”

Related Links:
Cornell University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.